Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Leader Regular Strength Chocolate Laxative Sennosides
Generic Name
Sennosides
Active Ingredient
SennosidesCategory
Other
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 15 mg/1 | TABLET | ORAL | 70000-0477 |
Detailed information about Leader Regular Strength Chocolate Laxative Sennosides
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Leader Regular Strength Chocolate Laxative Sennosides, you must consult a qualified healthcare professional.
Sennosides are a class of stimulant laxatives derived from the Senna plant, primarily used for the short-term treatment of constipation and as a bowel preparation agent before medical procedures. They work by stimulating the muscles of the colon to increase peristalsis.
For the treatment of occasional constipation in adults and children 12 years of age and older, the standard starting dose is typically 15 mg to 17.2 mg of sennosides (usually two 8.6 mg tablets) taken once daily. Clinical guidelines suggest that the maximum daily dose should not exceed 34.4 mg (four tablets) taken twice daily.
For bowel preparation before a medical procedure, the dosage is significantly higher and is determined by a specific clinical protocol. For example, a common regimen might involve taking 50 mg to 100 mg of sennosides in a single dose the day before the procedure, often in conjunction with a large volume of an osmotic laxative solution.
Sennosides should be used in children only under the guidance of a pediatrician. Dosage is typically based on age:
Because sennosides are minimally absorbed systemically, no formal dosage adjustments are required for patients with renal (kidney) impairment. However, these patients are at a higher risk for electrolyte imbalances if the medication causes significant diarrhea. Healthcare providers should monitor serum electrolytes in patients with advanced chronic kidney disease (CKD).
No dosage adjustments are typically necessary for patients with hepatic (liver) impairment. The localized action in the colon bypasses the need for extensive hepatic metabolism for the drug's primary effect.
Geriatric patients should start at the lowest possible dose. This population is more susceptible to dehydration and electrolyte depletion. Clinical monitoring for orthostatic hypotension (dizziness upon standing) and confusion related to dehydration is recommended.
Sennosides are most effective when taken at bedtime. This is because the medication typically takes 6 to 12 hours to produce a bowel movement, allowing the patient to have a movement the following morning.
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not 'double up' on doses to make up for a missed one, as this increases the risk of severe abdominal cramping and diarrhea.
Signs of a sennoside overdose include severe abdominal pain, persistent nausea, vomiting, and 'rice-water' diarrhea. Chronic overdose can lead to severe hypokalemia (low potassium levels), which may cause cardiac arrhythmias (irregular heartbeats) and muscle weakness. In the event of an acute overdose, seek emergency medical attention or contact a Poison Control Center immediately. Treatment is primarily supportive, focusing on rehydration and electrolyte replacement.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or use the medication for more than seven consecutive days without medical guidance.
The most frequently reported side effect of sennosides is abdominal cramping or 'griping.' This occurs because the medication stimulates the muscles of the colon to contract. While often uncomfortable, it is generally a sign that the medication is working. Most patients find that the cramping subsides once a bowel movement occurs.
Another common occurrence is the discoloration of urine. Sennosides can cause the urine to appear yellowish-brown, pink, or red. This is a harmless metabolic byproduct and is not a sign of blood in the urine or kidney damage. Patients should be reassured that this effect will disappear once the medication is discontinued.
> Warning: Stop taking Sennosides and call your doctor immediately if you experience any of these serious symptoms:
The chronic use of sennosides (beyond 7-10 days) can lead to 'cathartic colon.' This is a condition where the colon becomes dilated and loses its natural ability to contract, leading to a cycle of worsening constipation and a dependence on laxatives to have any bowel movement. Long-term use is also associated with chronic electrolyte disturbances and potential kidney damage (laxative nephropathy), although this is rare and usually associated with significant abuse.
No FDA black box warnings for Sennosides. However, the FDA requires a general warning on all stimulant laxative packaging regarding the risk of using the product when abdominal pain, nausea, or vomiting are present, as these may be signs of appendicitis or bowel obstruction.
Report any unusual symptoms to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.
Sennosides are intended for short-term relief only. They should not be used for more than seven consecutive days unless specifically directed by a physician. Self-treating chronic constipation with stimulant laxatives can mask serious underlying medical conditions, such as colorectal cancer or inflammatory bowel disease (IBD). Patients should be advised that the primary approach to constipation should involve increasing dietary fiber, fluid intake, and physical activity.
No FDA black box warnings for Sennosides.
For occasional, short-term use, no specific laboratory monitoring is required. However, for patients using sennosides under medical supervision for longer periods or at high doses (e.g., for bowel prep or chronic OIC), the following may be monitored:
Sennosides generally do not affect the ability to drive or operate machinery. However, if a patient experiences severe abdominal cramping or dizziness due to dehydration, they should avoid these activities until the symptoms resolve.
There is no direct chemical interaction between sennosides and alcohol. However, alcohol is a diuretic and can contribute to dehydration. Since sennosides also promote fluid loss in the stool, combining the two may increase the risk of dehydration and electrolyte imbalance.
If sennosides have been used for an extended period, they should not be stopped abruptly, as this can lead to 'rebound constipation.' A gradual tapering of the dose while simultaneously increasing dietary fiber and fluid intake is the recommended strategy for discontinuation.
> Important: Discuss all your medical conditions, especially any history of inflammatory bowel disease (Crohn's or ulcerative colitis), with your healthcare provider before starting Sennosides.
There are no absolute drug-drug contraindications where sennosides must never be used, provided the patient is under medical supervision. However, they should be avoided in combination with other potent stimulant laxatives (like bisacodyl) unless part of a specific medical bowel prep, as this significantly increases the risk of severe cramping and electrolyte depletion.
For each major interaction, the management strategy usually involves monitoring for symptoms of electrolyte imbalance and adjusting the timing of medication administration.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including other laxatives or stool softeners.
Sennosides must NEVER be used in the following conditions:
Conditions requiring careful risk-benefit analysis by a physician include:
Patients who have had an allergic reaction to other stimulant laxatives in the anthraquinone family, such as Aloe latex, Cascara Sagrada, or Rhubarb root, may also be sensitive to sennosides due to their similar chemical structures.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of abdominal surgeries, before prescribing or recommending Sennosides.
Sennosides are generally considered compatible with pregnancy when used occasionally and for short durations. They are often classified as 'Category C' (or considered low risk in newer labeling systems). Because sennosides are not significantly absorbed into the bloodstream, they are unlikely to reach the fetus in any meaningful amount. However, they can cause abdominal cramping which might be confused with uterine contractions. Pregnant women should always consult their obstetrician before using any laxative, as maintaining proper hydration and fiber intake is the preferred first-line approach.
Sennosides are considered safe for use during breastfeeding. Clinical studies have shown that the active metabolites (rhein) are excreted into breast milk in very small quantities. These amounts are typically insufficient to cause a change in the breastfed infant's stool consistency. The American Academy of Pediatrics (AAP) considers senna to be usually compatible with breastfeeding.
Sennosides are approved for use in children as young as 2 years old, but only under medical advice. In children, constipation is often behavioral (withholding) or dietary. Using stimulant laxatives without addressing the underlying cause can lead to a reliance on medication. Pediatricians typically recommend 'clean-out' phases followed by maintenance with osmotic laxatives (like polyethylene glycol) rather than long-term stimulant use.
Older adults are at an increased risk for side effects. Age-related declines in kidney function and a higher prevalence of polypharmacy (taking multiple medications) make this population more susceptible to dehydration and electrolyte imbalances. There is also a higher risk of 'fecal impaction' in the elderly, where a stimulant laxative might cause pain without successfully clearing the blockage. Healthcare providers should ensure the elderly patient is adequately hydrated.
In patients with significant renal impairment, the risk of electrolyte accumulation or depletion is heightened. While the drug itself doesn't require a dose change, the clinical management must be more vigilant. Monitoring of potassium and magnesium is essential if the patient experiences diarrhea.
No specific adjustments are needed for liver disease. However, in patients with advanced cirrhosis, electrolyte imbalances (especially hypokalemia) can trigger hepatic encephalopathy (brain dysfunction due to liver failure). Therefore, sennosides should be used cautiously in this specific sub-group.
> Important: Special populations require individualized medical assessment to ensure the benefits of sennoside use outweigh the potential risks.
Sennosides are dianthrone glycosides. They act as prodrugs that reach the colon intact. The beta-glycosidic bond is cleaved by colonic bacterial enzymes (beta-glycosidases), releasing the active aglycone, rheinanthrone. Rheinanthrone acts directly on the enterocytes (intestinal cells) and the intramural neuronal plexus. It induces a limited inflammatory response in the colonic mucosa, which stimulates the release of prostaglandins and nitric oxide. These signaling molecules increase the secretion of water and electrolytes into the lumen and stimulate the smooth muscle of the colon to contract, accelerating transit time.
The onset of action for sennosides is typically 6 to 12 hours after oral administration. The duration of effect is generally limited to the time it takes to evacuate the colon. There is a clear dose-response relationship; higher doses lead to more vigorous contractions and more liquid stools. Tolerance can develop with chronic use, requiring higher doses to achieve the same effect, which is why long-term use is discouraged.
| Parameter | Value |
|---|---|
| Bioavailability | <5% (systemic) |
| Protein Binding | 95% (for absorbed rhein) |
| Half-life | ~10 hours (metabolites) |
| Tmax | 6-12 hours (for clinical effect) |
| Metabolism | Colonic bacteria (primary); Liver (secondary) |
| Excretion | Fecal (>90%), Renal (<5%) |
Sennosides belong to the 'Stimulant Laxative' class. Other drugs in this class include bisacodyl and sodium picosulfate. They are distinct from osmotic laxatives (like Miralax), bulk-forming laxatives (like Psyllium), and stool softeners (like Docusate).
Common questions about Leader Regular Strength Chocolate Laxative Sennosides
Sennosides are primarily used for the short-term treatment of occasional constipation in adults and children. They are also frequently used as a bowel-cleansing agent to prepare the colon for medical procedures like colonoscopies or X-rays. By stimulating the muscles in the gut, they help move stool through the system more quickly. They are often used when other methods, like increasing fiber or water intake, have not been successful. Your doctor may also recommend them if you are taking medications, such as opioids, that are known to cause constipation.
The most common side effects include abdominal cramping, bloating, and gas, which occur as the medication stimulates the bowel to contract. Many patients also notice a harmless change in urine color to a reddish-brown or yellowish-orange hue. Mild nausea or diarrhea can also occur if the dose is higher than needed. These effects usually disappear once the medication is stopped or the bowels are cleared. If you experience severe pain or persistent vomiting, you should contact a healthcare provider immediately.
While there is no direct drug interaction between sennosides and alcohol, it is generally not recommended to consume alcohol while treating constipation. Alcohol is a diuretic, which can lead to dehydration and potentially worsen constipation in the long run. Since sennosides work by drawing water into the gut, being dehydrated can make the medication less effective or increase the risk of electrolyte imbalances. It is best to focus on drinking plenty of water and clear fluids while using this medication. Always consult your doctor for personalized advice regarding alcohol consumption.
Sennosides are generally considered safe for short-term use during pregnancy, as very little of the drug is absorbed into the mother's bloodstream. However, they are typically not the first choice for treating pregnancy-related constipation; doctors usually recommend fiber supplements or stool softeners first. Stimulant laxatives can sometimes cause abdominal cramps that might be uncomfortable or confusing during pregnancy. You should always speak with your obstetrician or healthcare provider before taking sennosides while pregnant. They can help you determine the safest and most effective way to manage your symptoms.
Sennosides typically take between 6 and 12 hours to produce a bowel movement. Because of this timeframe, most healthcare providers recommend taking the dose at bedtime so that a bowel movement occurs the following morning. The exact time can vary depending on the individual's metabolism and the amount of food in their system. If you do not have a bowel movement within 24 hours of taking the medication, you should consult your doctor rather than taking more doses. It is important not to rush the process by taking excessive amounts.
If you have only been taking sennosides for a few days as directed, you can stop taking them suddenly without any issues. However, if you have been using them for a long period, your body may have become dependent on them for regular bowel movements. Stopping abruptly after long-term use can lead to 'rebound' constipation, where the bowels become even more sluggish. In such cases, a doctor will usually recommend tapering the dose while increasing dietary fiber and water. Always follow the '7-day rule' and avoid long-term use unless directed by a physician.
If you miss a dose of sennosides, you can take it as soon as you remember, provided you still need the relief. However, if it is almost time for your next dose, it is better to skip the missed dose and stay on your regular schedule. Never take two doses at once to make up for a missed one, as this significantly increases the risk of severe stomach cramps and diarrhea. Since the medication is often taken at bedtime, missing a dose might simply mean you won't have a bowel movement the next morning. You can simply resume the treatment the following evening if needed.
Sennosides do not cause weight gain; in fact, some people mistakenly use them for weight loss, which is dangerous and ineffective. Any 'weight loss' experienced after taking a laxative is simply the loss of water and stool, not body fat. Chronic use for weight control can lead to severe dehydration, electrolyte imbalances, and permanent damage to the digestive system. Using sennosides in this way is considered a form of laxative abuse. If you are concerned about your weight, it is important to discuss healthy weight management strategies with a healthcare professional.
Sennosides can interact with several types of medications, particularly those that affect heart rhythm or potassium levels. For example, taking sennosides with 'water pills' (diuretics) or heart medications like digoxin can increase the risk of dangerous electrolyte imbalances. Additionally, because sennosides speed up the movement of the gut, they might prevent other oral medications from being fully absorbed. It is generally a good idea to take other medications at least two hours apart from sennosides. Always provide your doctor or pharmacist with a full list of all medications and supplements you are currently taking.
Yes, sennosides are widely available as a generic medication and are often the active ingredient in many store-brand laxatives. They are also the primary component in well-known brand-name products like Senokot and Ex-Lax. Generic versions are required by the FDA to have the same quality, strength, and purity as brand-name versions, and they are typically much more affordable. You can find sennosides in various forms, including tablets, liquids, and gummies, at most pharmacies and grocery stores. Check the 'Drug Facts' label on the packaging to confirm the active ingredient and dosage.
Other drugs with the same active ingredient (Sennosides)